CuraFi
  • Home
  • Platform
  • Health Plans
  • Blog
  • Drug Index
  • About Us
  • Contact
Sign in Subscribe

Provider

State of Biosimilars in 2023 and Looking Ahead to 2024

State of Biosimilars in 2023 and Looking Ahead to 2024

As 2023 draws to a close, the world of pharmaceuticals is abuzz with the transformative potential of biosimilars. Unlike traditional generic drugs, which are exact replicas of small-molecule branded medications, biosimilars are near-copies of complex biologic drugs produced by different manufacturers. The burgeoning biosimilar market in the U.S. is
Andrew Ninh Sep 26, 2023

Subscribe to CuraFi

Don't miss out on the latest news. Sign up now to get access to the library of members-only articles.
Cura Financial, Inc. © 2025.